🇺🇸 FDA
Patent

US 10226523

Clostridium difficile vaccine and methods of use

granted A61KA61K2039/545A61K2039/55566

Quick answer

US patent 10226523 (Clostridium difficile vaccine and methods of use) held by The Board of Regents of the University of Oklahoma expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/545, A61K2039/55566, A61K2039/58, A61K38/4893